Mills IG - Search Results

1

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.

Sharma NL, Massie CE, Ramos-Montoya A, Zecchini V, Scott HE, Lamb AD, MacArthur S, Stark R, Warren AY, Mills IG, Neal DE. Sharma NL, et al. Among authors: mills ig. Cancer Cell. 2013 Jan 14;23(1):35-47. doi: 10.1016/j.ccr.2012.11.010. Epub 2012 Dec 20. Cancer Cell. 2013. PMID: 23260764 Free article.

2

Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors.

Mills IG, Gaughan L, Robson C, Ross T, McCracken S, Kelly J, Neal DE. Mills IG, et al. J Cell Biol. 2005 Jul 18;170(2):191-200. doi: 10.1083/jcb.200503106. J Cell Biol. 2005. PMID: 16027218 Free PMC article.

3

A role for neurotensin in bicalutamide resistant prostate cancer cells.

Vias M, Burtt G, Culig Z, Veerakumarasivam A, Neal DE, Mills IG. Vias M, et al. Among authors: mills ig. Prostate. 2007 Feb 1;67(2):190-202. doi: 10.1002/pros.20518. Prostate. 2007. PMID: 17044078

4

New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

Massie CE, Adryan B, Barbosa-Morais NL, Lynch AG, Tran MG, Neal DE, Mills IG. Massie CE, et al. Among authors: mills ig. EMBO Rep. 2007 Sep;8(9):871-8. doi: 10.1038/sj.embor.7401046. Epub 2007 Aug 17. EMBO Rep. 2007. PMID: 17721441 Free PMC article.

5

Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer.

Aitchison AA, Veerakumarasivam A, Vias M, Kumar R, Hamdy FC, Neal DE, Mills IG. Aitchison AA, et al. Among authors: mills ig. Prostate. 2008 May 1;68(6):661-74. doi: 10.1002/pros.20730. Prostate. 2008. PMID: 18213629

6

Structural basis for the nuclear import of the human androgen receptor.

Cutress ML, Whitaker HC, Mills IG, Stewart M, Neal DE. Cutress ML, et al. Among authors: mills ig. J Cell Sci. 2008 Apr 1;121(Pt 7):957-68. doi: 10.1242/jcs.022103. Epub 2008 Mar 4. J Cell Sci. 2008. PMID: 18319300

7

Alterations in beta-catenin expression and localization in prostate cancer.

Whitaker HC, Girling J, Warren AY, Leung H, Mills IG, Neal DE. Whitaker HC, et al. Among authors: mills ig. Prostate. 2008 Aug 1;68(11):1196-205. doi: 10.1002/pros.20780. Prostate. 2008. PMID: 18459111

8

Pro-neural transcription factors as cancer markers.

Vias M, Massie CE, East P, Scott H, Warren A, Zhou Z, Nikitin AY, Neal DE, Mills IG. Vias M, et al. Among authors: mills ig. BMC Med Genomics. 2008 May 19;1:17. doi: 10.1186/1755-8794-1-17. BMC Med Genomics. 2008. PMID: 18489756 Free PMC article.

9

Terminal and progenitor lineage-survival oncogenes as cancer markers.

Vias M, Ramos-Montoya A, Mills IG. Vias M, et al. Among authors: mills ig. Trends Mol Med. 2008 Nov;14(11):486-94. doi: 10.1016/j.molmed.2008.09.002. Epub 2008 Oct 15. Trends Mol Med. 2008. PMID: 18929510 Clinical Trial.

10

AURKA overexpression accompanies dysregulation of DNA-damage response genes in invasive urothelial cell carcinoma.

Veerakumarasivam A, Goldstein LD, Saeb-Parsy K, Scott HE, Warren A, Thorne NP, Mills IG, Venkitaraman A, Neal DE, Kelly JD. Veerakumarasivam A, et al. Among authors: mills ig. Cell Cycle. 2008 Nov 15;7(22):3525-33. doi: 10.4161/cc.7.22.7042. Epub 2008 Nov 18. Cell Cycle. 2008. PMID: 19001879 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters